查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1452712

全球心血管手術設備市場、規模、佔有率、預測（2024-2032）、產業趨勢、成長、考量、主要公司分析

Cardiovascular Surgical Devices Market, Size, Share, Global Forecast 2024-2032, Industry Trends, Growth, Insight, Top Companies Analysis
出版日期: | 出版商: Renub Research | 英文 200 Pages | 商品交期: 最快1-2個工作天內

價格

預計2032年，全球心血管手術設備市場規模將達27.7億美元。 近年來，心血管手術設備因其對患者治療的重大影響而受到醫療界的關注。 這些設備提供了解決許多心血管疾病的現代解決方案，從微創過程到精細的外科手術。 其準確性、有效性以及縮短患者復原時間的能力吸引了世界各地醫療保健專業人員的注意。 此外，技術進步提高了這些設備的保護和性能，使它們對尋求現代心血管醫學頂級結果的醫生和患者越來越有吸引力。

2024年至2032年，心血管手術器械的市場規模預計將以3.46%的複合年增長率成長。

心臟病、糖尿病和生活方式相關疾病的迅速增加極大地促進了心臟手術設備市場的成長。 據世界衛生組織 (WHO) 稱，心血管疾病 (CVD) 是全球頭號死亡原因，每年奪走約 1,790 萬人的生命。 超過五分之四的 CVD 相關死亡是由於心臟病發作和中風造成的，其中三分之一發生在 70 歲之前。 心臟病和中風的主要行為風險包括不良營養模式、缺乏體力活動、吸菸和過量飲酒。

在過去的十年中，心臟設備技術的進步及其警訊推動了心血管手術設備市場的發展。 改良的技術可以帶來更好的患者治療效果、更短的復原時間和更高的滿意度。 人工智慧就是這樣一種技術，它將透過提供先進的監測功能來極大地增強心臟病學。 例如，2023年，Eko推出了SENSORA(TM)心臟病檢測平台。 該平台使用人工智慧來檢測結構性雜音並幫助診斷瓣膜性心臟病。 擴展的工具指標擴大了解決各種心血管問題的範圍，推動市場成長和採用。 因此，2023年心血管手術設備市場規模將達20.4億美元。

對發展中市場對心血管手術設備不斷增長的需求的反應也有助於市場擴張。 例如，雅培於 2022 年推出了現代技術的經導管主動脈瓣植入 (TAVI) 設備 Navitor，增加了印度高風險主動脈瓣狹窄患者獲得微創治療的機會。 主動脈瓣狹窄是一種常見且嚴重的冠狀動脈瓣膜疾病，可能沒有症狀。 然而，根據美國國立衛生研究院 (NIH) 的數據，印度每 1000 人中就有 4.54 人患有這種疾病。

此外，監管機構對創新產品的批准激增正在廣泛推動市場成長。 此外，產品發佈、批准、策略性收購和改進是心血管手術設備市場參與者維持和擴大其全球影響力所採用的關鍵企業技術。 例如，2023 年，雅培(Abbott) 與心血管系統公司(Cardioangio Systems, Inc.) 簽署了一項最終協議，雅培(Abbott) 收購CSI，一家以用於解決外周和動脈疾病的創新斑塊切除機而聞名的醫療器材公司。 透過此次收購，雅培預計將利用 CSI 的補充技術來擴大其主要血管設備的產品組合。

心律不整在心血管手術設備市場中扮演重要角色。

根據應用，心血管手術設備市場分為先天性心臟病、心律不整、冠狀動脈疾病、充血性心臟衰竭等。 由於心律不整的普遍性和危及生命的影響，心律不整在心血管手術器械市場中至關重要。 這刺激了對起搏器和導管消融結構等現代解決方案的需求。 例如，波士頓科學公司(Boston Scientific Corporation) 的FARAPULSE™ 脈衝場消融(PFA) 系統於2024 年獲得FDA 批准，這是一種治療藥物難治性、復發性、症狀性和陣發性心房顫動的獨特技術。

本報告研究了全球心血管手術設備市場，並對市場動態、細分市場、地區和公司進行了全面分析。

目錄

第一章簡介

第二章研究方法

第 3 章執行摘要

第 4 章市場動態

  • 生長促進因素
  • 作業

第五章心血管手術設備市場

第六章市佔率-心血管手術設備市場

  • 依產品類型
  • 依用途
  • 依最終用戶
  • 依國家/地區

第七章產品類型-心血管手術設備市場

  • 心跳手術系統
  • 心肺機
  • 心臟消融設備
  • 一次性灌溉用品

第8章應用-心血管手術設備市場

  • 先天性心臟病
  • 心律不整
  • 冠狀動脈疾病
  • 充血性心臟衰竭
  • 其他

第 9 章最終使用者 - 心血管手術設備市場

  • 醫院
  • 門診手術中心
  • 其他

第10章國家-心血管手術設備市場

  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 法國
    • 德國
    • 義大利
    • 西班牙
    • 英國
    • 比利時
    • 荷蘭
    • 土耳其
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 泰國
    • 馬來西亞
    • 印尼
    • 澳大利亞
    • 紐西蘭
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東/非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第 11 章波特五力分析 - 心臟手術設備市場

第十二章 SWOT 分析 - 心臟手術設備市場

第十三章主要公司分析

  • Abbott Laboratories
  • Boston Scientific Corporation
  • Edwards Lifesciences
  • Cardinal Health Inc.
  • Medtronic PLC
  • GE Healthcare
  • LivaNova PLC
  • Terumo Corporation

Cardiovascular Surgical Devices Market is predicted to reach US$ 2.77 Billion by 2032, according to Renub Research. Lately, cardiovascular surgical gadgets have received prominence inside the healthcare sector thanks to their large impact on affected person remedy. These devices give modern solutions for addressing numerous cardiovascular illnesses, spanning from minimally invasive processes to elaborate surgical procedures. Their precision, effectiveness, and ability to shorten affected person restoration durations have captured the interest of healthcare specialists globally. Moreover, technological progressions have improved the protection and performance of these devices, rendering them increasingly attractive to both practitioners and sufferers looking for top-rated consequences in contemporary cardiovascular healthcare.

Cardiovascular Surgical Devices Market is anticipated to increase at a CAGR of 3.46% from 2024 to 2032

The surge in cardiac illnesses, diabetes, and lifestyle disorders contributes considerably to the growth of the cardiac surgical devices market. According to the World Health Organization (WHO), cardiovascular diseases (CVDs) are the primary global reason of mortality, claiming approximately 17.9 million lives yearly. Over four-fifths of CVD-related deaths stem from heart attacks and strokes, with a third occurring prematurely in individuals under 70. Key behavioral risk elements for heart sickness and stroke encompass harmful nutritional patterns, a loss of physical activity, tobacco consumption, and excessive alcohol consumption.

Over the past decade, improvements in cardiac device technologies and their warning signs have propelled the cardiovascular surgical devices market. Improved technology yields higher patient outcomes, shorter recovery instances, and higher satisfaction rates. Artificial intelligence is one such technology that substantially enhances cardiology by imparting advanced monitoring abilities. For example, in 2023, Eko launched the SENSORA(TM) Cardiac Disease Detection Platform, which uses AI to detect structural murmurs, aiding in valvular heart disorder diagnosis. Expanded tool indicators widen their scope in addressing diverse cardiovascular issues, fostering market growth and adoption. Hence, the Cardiovascular Surgical Devices Market was worth US$ 2.04 Billion in 2023.

The reaction to heightened demands for cardiovascular surgical devices in developing nations also contributed to the market boom. For instance, in 2022, Abbott launched its contemporary-technology transcatheter aortic valve implantation (TAVI) device, Navitor, which increased access to minimally invasive remedies for intense aortic stenosis patients in India at excessive or intense surgical danger. Aortic stenosis, a general and severe coronary heart valve disorder, frequently lacks considerable signs. However, 4.54 per thousand individuals in India suffer from this condition, according to the National Institutes of Health (NIH).

Moreover, the surge in approvals from the regulatory authorities for groundbreaking products extensively drives the market's growth. Also, product launches, approvals, strategic acquisitions, and improvements are vital enterprise techniques employed by cardiovascular surgical devices market participants to maintain and expand their worldwide presence. For example, in 2023, Abbott and Cardiovascular Systems, Inc. disclosed a definitive agreement for Abbott to gather CSI, a medical device corporation famous for its revolutionary atherectomy machine used in addressing peripheral and artery disease. This acquisition will augment Abbott's leading vascular device portfolio with complementary technologies from CSI.

Cardiac arrhythmia plays a crucial role in the market for cardiovascular surgical devices

Based on Application, the Cardiovascular Surgical Devices Market is categorized into Congenital Heart Defects, Cardiac Arrhythmia, Coronary Heart Disease, Congestive Heart Failure, and Others. Cardiac arrhythmia is pivotal in the cardiovascular surgical devices market because of its prevalence and life-threatening implications. This spurs demand for modern solutions like pacemakers and catheter ablation structures. For instance, in 2024, Boston Scientific Corporation received FDA approval for the FARAPULSE(TM) Pulsed Field Ablation (PFA) System, offering a unique technique for treating drug-refractory, recurrent, symptomatic, paroxysmal atrial fibrillation.

China significantly influences the market for cardiovascular surgical devices

The Cardiovascular Surgical Devices Market is split by country, including North America (United States, Canada), Europe (France, Germany, Italy, Spain, United Kingdom, Belgium, the Netherlands, and Turkey), Asia Pacific (China, Japan, India, Australia, South Korea, Thailand, Malaysia, Indonesia, and New Zealand), Latin America (Brazil, Mexico, and Argentina), Middle East & Africa (South Africa, Saudi Arabia, and the United Arab Emirates). China is important in the cardiovascular surgical devices market. This is due to its vast population, rising cardiovascular disorder rates, expanding healthcare infrastructure, increasing healthcare expenditure, and developing need for superior scientific technologies. For instance, in July 2022, China's National Medical Products Administration permitted an artificial coronary heart for excessive heart failure created by the China Academy of Launch Vehicle Technology and TEDA International Cardiovascular Hospital.

Key Players

The Cardiovascular Surgical Devices Market includes companies such as Abbott Laboratories, Boston Scientific Corporation, Edwards Lifesciences, Cardinal Health Inc., Medtronic PLC, GE Healthcare, LivaNova PLC, and Terumo Corporation.

Product Type - Market breakup in 4 viewpoints:

1. Beating Heart Surgery Systems

2. Cardiopulmonary Bypass Equipment

3. Cardiac Ablation Devices

4. Perfusion Disposable

Application - Market breakup in 5 viewpoints:

1. Congenital Heart Defects

2. Cardiac Arrhythmia

3. Coronary Heart Disease

4. Congestive Heart Failure

5. Others

End-User - Market breakup in 3 viewpoints:

1. Hospitals

2. Ambulatory Surgical Centers

3. Others

Country - Market of 25 Countries Covered in the Report:

1. North America

  • 1.1 United States
  • 1.2 Canada

2. Europe

  • 2.1 France
  • 2.2 Germany
  • 2.3 Italy
  • 2.4 Spain
  • 2.5 United Kingdom
  • 2.6 Belgium
  • 2.7 Netherland
  • 2.8 Turkey

3. Asia Pacific

  • 3.1 China
  • 3.2 Japan
  • 3.3 India
  • 3.4 South Korea
  • 3.5 Thailand
  • 3.6 Malaysia
  • 3.7 Indonesia
  • 3.8 Australia
  • 3.9 New Zealand

4. Latin America

  • 4.1 Brazil
  • 4.2 Mexico
  • 4.3 Argentina

5. Middle East & Africa

  • 5.1 Saudi Arabia
  • 5.2 UAE
  • 5.3 South Africa

All the Key players have been covered from 3 Viewpoints:

  • Overview
  • Recent Development
  • Revenue Analysis

Company Analysis:

1. Abbott Laboratories

2. Boston Scientific Corporation

3. Edwards Lifesciences

4. Cardinal Health Inc.

5. Medtronic PLC

6. GE Healthcare

7. LivaNova PLC

8. Terumo Corporation

Table of Contents

1. Introduction

2. Research Methodology

3. Executive Summary

4. Market Dynamics

  • 4.1 Growth Drivers
  • 4.2 Challenges

5. Cardiovascular Surgical Devices Market

6. Market Share - Cardiovascular Surgical Devices Market

  • 6.1 By Product Type
  • 6.2 By Application
  • 6.3 By End User
  • 6.4 By Countries

7. Product Type - Cardiovascular Surgical Devices Market

  • 7.1 Beating Heart Surgery Systems
  • 7.2 Cardiopulmonary Bypass Equipment
  • 7.3 Cardiac Ablation Devices
  • 7.4 Perfusion Disposable

8. Application - Cardiovascular Surgical Devices Market

  • 8.1 Congential Heart Defects
  • 8.2 Cardiac Arrthymia
  • 8.3 Coronary Heart Disease
  • 8.4 Congestive Heart Failure
  • 8.5 Others

9. End User - Cardiovascular Surgical Devices Market

  • 9.1 Hospitals
  • 9.2 Ambulatory Surgical Centers
  • 9.3 Others

10. Countries - Cardiovascular Surgical Devices Market

  • 10.1 North America
    • 10.1.1 United States
    • 10.1.2 Canada
  • 10.2 Europe
    • 10.2.1 France
    • 10.2.2 Germany
    • 10.2.3 Italy
    • 10.2.4 Spain
    • 10.2.5 United Kingdom
    • 10.2.6 Belgium
    • 10.2.7 Netherland
    • 10.2.8 Turkey
  • 10.3 Asia Pacific
    • 10.3.1 China
    • 10.3.2 Japan
    • 10.3.3 India
    • 10.3.4 South Korea
    • 10.3.5 Thailand
    • 10.3.6 Malaysia
    • 10.3.7 Indonesia
    • 10.3.8 Australia
    • 10.3.9 New Zealand
  • 10.4 Latin America
    • 10.4.1 Brazil
    • 10.4.2 Mexico
    • 10.4.3 Argentina
  • 10.5 Middle East & Africa
    • 10.5.1 Saudi Arabia
    • 10.5.2 UAE
    • 10.5.3 South Africa

11. Porter's Five Forces Analysis - Cardiac Surgery Devices Market

  • 11.1 Bargaining Power of Buyers
  • 11.2 Bargaining Power of Suppliers
  • 11.3 Degree of Rivalry
  • 11.4 Threat of New Entrants
  • 11.5 Threat of Substitutes

12. SWOT Analysis - Cardiac Surgery Devices Market

  • 12.1 Strength
  • 12.2 Weakness
  • 12.3 Opportunity
  • 12.4 Threat

13. Key Players Analysis

  • 13.1 Abbott Laboratories
    • 13.1.1 Overview
    • 13.1.2 Recent Development
    • 13.1.3 Revenue Analysis
  • 13.2 Boston Scientific Corporation
    • 13.2.1 Overview
    • 13.2.2 Recent Development
    • 13.2.3 Revenue Analysis
  • 13.3 Edwards Lifesciences
    • 13.3.1 Overview
    • 13.3.2 Recent Development
    • 13.3.3 Revenue Analysis
  • 13.4 Cardinal Health Inc.
    • 13.4.1 Overview
    • 13.4.2 Recent Development
    • 13.4.3 Revenue Analysis
  • 13.5 Medtronic PLC
    • 13.5.1 Overview
    • 13.5.2 Recent Development
    • 13.5.3 Revenue Analysis
  • 13.6 GE Healthcare
    • 13.6.1 Overview
    • 13.6.2 Recent Development
    • 13.6.3 Revenue Analysis
  • 13.7 LivaNova PLC
    • 13.7.1 Overview
    • 13.7.2 Recent Development
    • 13.7.3 Revenue Analysis
  • 13.8 Terumo Corporation
    • 13.8.1 Overview
    • 13.8.2 Recent Development
    • 13.8.3 Revenue Analysis

List of Figures

  • Figure-01: Global - Cardiovascular Surgical Devices Market (Billion US$), 2019 - 2023
  • Figure-02: Global - Forecast for Cardiovascular Surgical Devices Market (Billion US$), 2024 - 2032
  • Figure-03: Product Type - Beating Heart Surgery Systems Market (Million US$), 2019 - 2023
  • Figure-04: Product Type - Forecast for Beating Heart Surgery Systems Market (Million US$), 2024 - 2032
  • Figure-05: Product Type - Cardiopulmonary Bypass Equipment Market (Million US$), 2019 - 2023
  • Figure-06: Product Type - Forecast for Cardiopulmonary Bypass Equipment Market (Million US$), 2024 - 2032
  • Figure-07: Product Type - Cardiac Ablation Devices Market (Million US$), 2019 - 2023
  • Figure-08: Product Type - Forecast for Cardiac Ablation Devices Market (Million US$), 2024 - 2032
  • Figure-09: Product Type - Perfusion Disposable Market (Million US$), 2019 - 2023
  • Figure-10: Product Type - Forecast for Perfusion Disposable Market (Million US$), 2024 - 2032
  • Figure-11: Application - Congential Heart Defects Market (Million US$), 2019 - 2023
  • Figure-12: Application - Forecast for Congential Heart Defects Market (Million US$), 2024 - 2032
  • Figure-13: Application - Cardiac Arrthymia Market (Million US$), 2019 - 2023
  • Figure-14: Application - Forecast for Cardiac Arrthymia Market (Million US$), 2024 - 2032
  • Figure-15: Application - Coronary Heart Disease Market (Million US$), 2019 - 2023
  • Figure-16: Application - Forecast for Coronary Heart Disease Market (Million US$), 2024 - 2032
  • Figure-17: Application - Congestive Heart Failure Market (Million US$), 2019 - 2023
  • Figure-18: Application - Forecast for Congestive Heart Failure Market (Million US$), 2024 - 2032
  • Figure-19: Application - Others Market (Million US$), 2019 - 2023
  • Figure-20: Application - Forecast for Others Market (Million US$), 2024 - 2032
  • Figure-21: End User - Hospitals Market (Million US$), 2019 - 2023
  • Figure-22: End User - Forecast for Hospitals Market (Million US$), 2024 - 2032
  • Figure-23: End User - Ambulatory Surgical Centers Market (Million US$), 2019 - 2023
  • Figure-24: End User - Forecast for Ambulatory Surgical Centers Market (Million US$), 2024 - 2032
  • Figure-25: End User - Others Market (Million US$), 2019 - 2023
  • Figure-26: End User - Forecast for Others Market (Million US$), 2024 - 2032
  • Figure-27: United States - Cardiovascular Surgical Devices Market (Million US$), 2019 - 2023
  • Figure-28: United States - Forecast for Cardiovascular Surgical Devices Market (Million US$), 2024 - 2032
  • Figure-29: Canada - Cardiovascular Surgical Devices Market (Million US$), 2019 - 2023
  • Figure-30: Canada - Forecast for Cardiovascular Surgical Devices Market (Million US$), 2024 - 2032
  • Figure-31: France - Cardiovascular Surgical Devices Market (Million US$), 2019 - 2023
  • Figure-32: France - Forecast for Cardiovascular Surgical Devices Market (Million US$), 2024 - 2032
  • Figure-33: Germany - Cardiovascular Surgical Devices Market (Million US$), 2019 - 2023
  • Figure-34: Germany - Forecast for Cardiovascular Surgical Devices Market (Million US$), 2024 - 2032
  • Figure-35: Italy - Cardiovascular Surgical Devices Market (Million US$), 2019 - 2023
  • Figure-36: Italy - Forecast for Cardiovascular Surgical Devices Market (Million US$), 2024 - 2032
  • Figure-37: Spain - Cardiovascular Surgical Devices Market (Million US$), 2019 - 2023
  • Figure-38: Spain - Forecast for Cardiovascular Surgical Devices Market (Million US$), 2024 - 2032
  • Figure-39: United Kingdom - Cardiovascular Surgical Devices Market (Million US$), 2019 - 2023
  • Figure-40: United Kingdom - Forecast for Cardiovascular Surgical Devices Market (Million US$), 2024 - 2032
  • Figure-41: Belgium - Cardiovascular Surgical Devices Market (Million US$), 2019 - 2023
  • Figure-42: Belgium - Forecast for Cardiovascular Surgical Devices Market (Million US$), 2024 - 2032
  • Figure-43: Netherland - Cardiovascular Surgical Devices Market (Million US$), 2019 - 2023
  • Figure-44: Netherland - Forecast for Cardiovascular Surgical Devices Market (Million US$), 2024 - 2032
  • Figure-45: Turkey - Cardiovascular Surgical Devices Market (Million US$), 2019 - 2023
  • Figure-46: Turkey - Forecast for Cardiovascular Surgical Devices Market (Million US$), 2024 - 2032
  • Figure-47: China - Cardiovascular Surgical Devices Market (Million US$), 2019 - 2023
  • Figure-48: China - Forecast for Cardiovascular Surgical Devices Market (Million US$), 2024 - 2032
  • Figure-49: Japan - Cardiovascular Surgical Devices Market (Million US$), 2019 - 2023
  • Figure-50: Japan - Forecast for Cardiovascular Surgical Devices Market (Million US$), 2024 - 2032
  • Figure-51: India - Cardiovascular Surgical Devices Market (Million US$), 2019 - 2023
  • Figure-52: India - Forecast for Cardiovascular Surgical Devices Market (Million US$), 2024 - 2032
  • Figure-53: South Korea - Cardiovascular Surgical Devices Market (Million US$), 2019 - 2023
  • Figure-54: South Korea - Forecast for Cardiovascular Surgical Devices Market (Million US$), 2024 - 2032
  • Figure-55: Thailand - Cardiovascular Surgical Devices Market (Million US$), 2019 - 2023
  • Figure-56: Thailand - Forecast for Cardiovascular Surgical Devices Market (Million US$), 2024 - 2032
  • Figure-57: Malaysia - Cardiovascular Surgical Devices Market (Million US$), 2019 - 2023
  • Figure-58: Malaysia - Forecast for Cardiovascular Surgical Devices Market (Million US$), 2024 - 2032
  • Figure-59: Indonesia - Cardiovascular Surgical Devices Market (Million US$), 2019 - 2023
  • Figure-60: Indonesia - Forecast for Cardiovascular Surgical Devices Market (Million US$), 2024 - 2032
  • Figure-61: Australia - Cardiovascular Surgical Devices Market (Million US$), 2019 - 2023
  • Figure-62: Australia - Forecast for Cardiovascular Surgical Devices Market (Million US$), 2024 - 2032
  • Figure-63: New Zealand - Cardiovascular Surgical Devices Market (Million US$), 2019 - 2023
  • Figure-64: New Zealand - Forecast for Cardiovascular Surgical Devices Market (Million US$), 2024 - 2032
  • Figure-65: Brazil - Cardiovascular Surgical Devices Market (Million US$), 2019 - 2023
  • Figure-66: Brazil - Forecast for Cardiovascular Surgical Devices Market (Million US$), 2024 - 2032
  • Figure-67: Mexico - Cardiovascular Surgical Devices Market (Million US$), 2019 - 2023
  • Figure-68: Mexico - Forecast for Cardiovascular Surgical Devices Market (Million US$), 2024 - 2032
  • Figure-69: Argentina - Cardiovascular Surgical Devices Market (Million US$), 2019 - 2023
  • Figure-70: Argentina - Forecast for Cardiovascular Surgical Devices Market (Million US$), 2024 - 2032
  • Figure-71: Saudi Arabia - Cardiovascular Surgical Devices Market (Million US$), 2019 - 2023
  • Figure-72: Saudi Arabia - Forecast for Cardiovascular Surgical Devices Market (Million US$), 2024 - 2032
  • Figure-73: UAE - Cardiovascular Surgical Devices Market (Million US$), 2019 - 2023
  • Figure-74: UAE - Forecast for Cardiovascular Surgical Devices Market (Million US$), 2024 - 2032
  • Figure-75: South Africa - Cardiovascular Surgical Devices Market (Million US$), 2019 - 2023
  • Figure-76: South Africa - Forecast for Cardiovascular Surgical Devices Market (Million US$), 2024 - 2032
  • Figure-77: Abbott Laboratories - Global Revenue (Million US$), 2019 - 2023
  • Figure-78: Abbott Laboratories - Forecast for Global Revenue (Million US$), 2024 - 2032
  • Figure-79: Boston Scientific Corporation - Global Revenue (Million US$), 2019 - 2023
  • Figure-80: Boston Scientific Corporation - Forecast for Global Revenue (Million US$), 2024 - 2032
  • Figure-81: Edwards Lifesciences - Global Revenue (Million US$), 2019 - 2023
  • Figure-82: Edwards Lifesciences - Forecast for Global Revenue (Million US$), 2024 - 2032
  • Figure-83: Cardinal Health Inc. - Global Revenue (Million US$), 2019 - 2023
  • Figure-84: Cardinal Health Inc. - Forecast for Global Revenue (Million US$), 2024 - 2032
  • Figure-85: Medtronic PLC - Global Revenue (Million US$), 2019 - 2023
  • Figure-86: Medtronic PLC - Forecast for Global Revenue (Million US$), 2024 - 2032
  • Figure-87: GE Healthcare - Global Revenue (Million US$), 2019 - 2023
  • Figure-88: GE Healthcare - Forecast for Global Revenue (Million US$), 2024 - 2032
  • Figure-89: LivaNova PLC - Global Revenue (Million US$), 2019 - 2023
  • Figure-90: LivaNova PLC - Forecast for Global Revenue (Million US$), 2024 - 2032
  • Figure-91: Terumo Corporation - Global Revenue (Million US$), 2019 - 2023
  • Figure-92: Terumo Corporation - Forecast for Global Revenue (Million US$), 2024 - 2032

List of Tables

  • Table-01: Global - Cardiovascular Surgical Devices Market Share by Product Type (Percent), 2019 - 2023
  • Table-02: Global - Forecast for Cardiovascular Surgical Devices Market Share by Product Type (Percent), 2024 - 2032
  • Table-03: Global - Cardiovascular Surgical Devices Market Share by Application (Percent), 2019 - 2023
  • Table-04: Global - Forecast for Cardiovascular Surgical Devices Market Share by Application (Percent), 2024 - 2032
  • Table-05: Global - Cardiovascular Surgical Devices Market Share by End User (Percent), 2019 - 2023
  • Table-06: Global - Forecast for Cardiovascular Surgical Devices Market Share by End User (Percent), 2024 - 2032
  • Table-07: Global - Cardiovascular Surgical Devices Market Share by Countries (Percent), 2019 - 2023
  • Table-08: Global - Forecast for Cardiovascular Surgical Devices Market Share by Countries (Percent), 2024 - 2032